Access to Medicine – Patents versus Patients
Fifa Rahman, Board Member, Unitaid NGO Delegation | Mark Cheong, Pharmacist, Monash University
You can share this podcast by copying this HTML to your clipboard and pasting into your blog or web page.
Price gouging in the pharmaceutical industry has become a common feature of health news. Who can forget Martin Shkreli’s infamous price hike of the HIV drug Daraprim, which went from USD13.50 to $750 in the summer of 2015? Are international laws tough enough to ensure that the bottom line is the people and not profit?
Produced by: Tina Carmillia
Presented by: Meera Sivasothy
Download the BFM mobile app. Stay at home and stay up-to-date.